| Product Information |
|
| Registration Number |
DRP-5972-05
|
| Generic Name |
Docetaxel (as trihydrate)
|
| Brand Name |
Doxetacent
|
| Dosage Strength |
20 mg/0.5 mL
|
| Dosage Form |
Concentrate Solution for I.V. Infusion
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antineoplastic (Taxane)
|
| Packaging |
One (1) box contains: USP Type I flint glass vial in 0.5 mL (net content as active) + USP Type I flint glass vial in 1.5 mL (net content as diluent) in a plastic tray. / (Box of 1’s)
|
| Manufacturer |
Getwell Pharma India Pvt. Ltd
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Ambica International Corporation
|
| Distributor |
Central West Medicale Inc
|
| Application Type |
CLIDP Conversion
|
| Issuance Date |
15 June 2024
|
| Expiry Date |
28 January 2030
|